SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-243776
Filing Date
2020-09-11
Accepted
2020-09-11 08:48:59
Documents
15
Period of Report
2020-09-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d34590d8k.htm   iXBRL 8-K 28683
2 EX-10.1 d34590dex101.htm EX-10.1 94036
3 EX-99.1 d34590dex991.htm EX-99.1 8669
7 GRAPHIC g34590g0911081642245.jpg GRAPHIC 5493
  Complete submission text file 0001193125-20-243776.txt   302797

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA svra-20200911.xsd EX-101.SCH 2738
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE svra-20200911_lab.xml EX-101.LAB 19617
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE svra-20200911_pre.xml EX-101.PRE 12278
8 EXTRACTED XBRL INSTANCE DOCUMENT d34590d8k_htm.xml XML 3658
Mailing Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746
Business Address 900 S. CAPITAL OF TEXAS HIGHWAY SUITE 150 AUSTIN TX 78746 512-614-1848
Savara Inc (Filer) CIK: 0001160308 (see all company filings)

IRS No.: 841318182 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32157 | Film No.: 201170032
SIC: 2834 Pharmaceutical Preparations